ARNA Genomics
PrivateLast Round
Series A
Sep 17, 2020
Total Funding Raised
$5M
Company Overview
ARNA Genomics is a biotechnology company that develops liquid biopsy technologies for early cancer detection through the analysis of cell-free DNA in blood plasma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ARNA Genomics Comparables
Compare ARNA Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acuamark Diagnostics | 90% | |
| Adela | 86% | |
| 4D Lifetec | 84% |
ARNA Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 17, 2020 | ||||
| Token Sale | Feb 11, 2018 |
Key People
Founding team and executive leadership
ARNA Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Xploration Capital | Series A |
| Iskra Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 17, 2020
$4M round led by Xploration Capital.
- Feb 11, 2018
$450K raised in Token Sale round.
ARNA Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ARNA Genomics's valuation, stock price, and market status.
Is ARNA Genomics a public or private company?
ARNA Genomics is a private company.
What is the current stock price of ARNA Genomics?
ARNA Genomics is a private company with no public stock price. No recent secondary market data is available.
How much is ARNA Genomics worth (valuation)?
Valuation information for ARNA Genomics is not publicly available.
Can I buy ARNA Genomics stock?
ARNA Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ARNA Genomics's last funding round?
ARNA Genomics's most recent funding round was Series A on September 17, 2020.
Who are the main investors in ARNA Genomics?
Key investors in ARNA Genomics include Xploration Capital.
Will ARNA Genomics IPO soon?
No public IPO plans have been announced for ARNA Genomics.
How can I track ARNA Genomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ARNA Genomics's secondary market activity and sign up for updates.